GO:0019534 toxin transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019534 (toxin transmembrane transporter activity) is a molecular function that enables the transfer of a toxin, typically a poisonous protein or peptide, across a membrane [1,4].
• Toxins can enter cells through both conventional and unconventional endocytic routes, and some toxins directly modulate ion channels such as NaV1.7 [2,4].
• Bacterial outer-membrane permeability and dedicated transport systems, such as the LptB2FGC complex, are critical for the transport of lipopolysaccharide (LPS), a bacterial toxin [5,7,8].
• The activity is relevant to pain signaling, bacterial virulence, and inflammatory diseases, including LPS-induced pyroptosis [4,6].
• Key proteins include TRPV1, TMEM233, LptC, LptB2FGC, SLC41A1, and various endocytic machinery components [1,2,4,5,6,7].
• CRISPR knockout, knock-in, point-mutation, and overexpression models are essential to dissect the causal roles of these transporters in disease.
Description
Toxin transmembrane transporter activity (GO:0019534) is a molecular function that enables the movement of a toxin, a poisonous compound typically of protein nature, from one side of a membrane to the other [1,4]. This activity is fundamental to how organisms interact with harmful substances, whether they are bacterial lipopolysaccharides (LPS), plant-derived pain-causing peptides, or endogenous toxic proteins [4,5,8]. Understanding this function is critical for researchers studying infectious diseases, pain mechanisms, and cellular stress responses [1,4,6]. The transport of toxins across membranes is not a passive process; it often requires specialized protein complexes and can be hijacked by pathogens to gain entry into host cells [2,5]. Recent studies have highlighted the role of unconventional endocytic mechanisms in toxin uptake, revealing new pathways that could be targeted therapeutically. Moreover, toxins can directly modulate host ion channels, as seen with stinging nettle toxins that target TMEM233 to modulate NaV1.7 function, thereby altering pain signaling. In bacteria, the transport of LPS across the outer membrane is mediated by the LptB2FGC complex, a multi-protein machine that is essential for outer membrane biogenesis and virulence [5,7]. The activity of these transporters is also linked to inflammatory responses, such as LPS-induced mitochondrial damage and pyroptosis in dental stem cells via SLC41A1-mediated magnesium efflux. Thus, GO:0019534 encompasses a diverse set of molecular events that are central to host-pathogen interactions and cellular physiology.
toxin transmembrane transporter activity At A Glance
| GO ID | GO:0019534 |
|---|---|
| GO term | toxin transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Enables the transfer of a toxin from one side of a membrane to the other |
| Definition source | QuickGO |
| Related biological process | Toxin transport, host-pathogen interaction, pain signaling |
| Example proteins | TRPV1, TMEM233, LptC, LptB2FGC, SLC41A1 |
| Disease relevance | Pain, bacterial infections, inflammatory diseases |
What Is GO:0019534?
According to the Gene Ontology, GO:0019534 (toxin transmembrane transporter activity) is defined as enabling the transfer of a toxin from one side of a membrane to the other. A toxin is a poisonous compound, typically a protein, that is produced by cells or organisms and can cause disease when introduced into the body or tissues of an organism. This activity is a molecular function that directly facilitates the movement of such toxic substances across biological membranes, often against a concentration gradient or through specific channels [1,4,5].
Why Is toxin transmembrane transporter activity Important in Cell Biology?
Toxin transmembrane transporter activity is important because it governs how cells and organisms handle poisonous substances, which is central to survival, immunity, and disease pathogenesis [1,4,8]. Many bacterial toxins, such as LPS, must be transported across membranes to exert their effects, and dedicated transport systems like the LptB2FGC complex are essential for this process [5,7]. In humans, the transport of toxins can modulate pain pathways, as seen with stinging nettle toxins that target TMEM233 to alter NaV1.7 function. Additionally, toxins can trigger inflammatory cell death, such as pyroptosis, through mechanisms involving ion transport. Therefore, understanding this activity provides insights into infectious diseases, pain management, and inflammatory disorders, and it offers potential targets for therapeutic intervention [2,4,6].
• Enables the transport of bacterial toxins like LPS, which is critical for outer membrane integrity and virulence [5,7,8].
• Facilitates the entry of plant-derived toxins that modulate pain signaling through ion channels.
• Plays a role in unconventional endocytic mechanisms that pathogens exploit for cell entry.
• Links toxin transport to inflammatory responses, including pyroptosis and mitochondrial damage.
• Involves ion channels such as TRPV1, which are targets for pain relief.
• Contributes to natural product-drug interactions via transporter-mediated processes.
• Provides potential targets for antibacterial and anti-inflammatory therapies [5,6].
• Is essential for understanding host-pathogen interactions at the molecular level [2,4].
• Helps explain how toxins cross biological membranes in both prokaryotes and eukaryotes [1,8].
• Supports the development of CRISPR-based models to study toxin transport in disease [4,6].
What Happens During toxin transmembrane transporter activity?
Toxin recognition and binding
In simple terms: The transporter first recognizes and grabs onto the toxin.
The process begins when a transporter protein or complex binds to a toxin molecule. This binding is often specific and can involve protein-protein interactions, as seen with stinging nettle toxins that target TMEM233 to modulate NaV1.7 function. In bacteria, the LptB2FGC complex recognizes LPS and prepares it for transport across the periplasm [5,7]. The initial binding step is critical for determining substrate specificity and initiating the transport cycle [1,5].
Membrane translocation
In simple terms: The toxin is moved across the membrane through a channel or transporter.
Once bound, the toxin is translocated across the lipid bilayer. This can occur through dedicated protein complexes, such as the LptB2FGC transporter, which uses conformational changes to extract LPS from the inner membrane and move it to the outer membrane [5,7]. In eukaryotic cells, toxins can enter via unconventional endocytic mechanisms that bypass classical clathrin-mediated pathways. The translocation step often requires energy and can be regulated by accessory proteins [5,8].
Release and downstream effects
In simple terms: After crossing the membrane, the toxin is released and can cause harm.
Following translocation, the toxin is released on the other side of the membrane, where it can exert its toxic effects. For example, LPS can trigger inflammatory signaling, leading to mitochondrial damage and pyroptosis in dental stem cells via SLC41A1-mediated magnesium efflux. In pain pathways, toxins that modulate NaV1.7 can alter neuronal excitability and pain perception. The release step is often coupled to cellular responses that contribute to disease pathogenesis [1,6].
Regulation of transport activity
In simple terms: The transport process is controlled by various cellular signals.
Toxin transport activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and interactions with other proteins. For instance, the LptB2FGC complex is regulated by conformational plasticity of LptC, which influences LPS transport efficiency. In eukaryotic cells, endocytic mechanisms can be modulated by signaling pathways, affecting toxin uptake. Additionally, natural product-drug interactions can influence transporter activity, as reviewed by Bi et al.. Understanding these regulatory mechanisms is key to targeting toxin transport in disease [3,5].
Key Genes Involved in GO:0019534 toxin transmembrane transporter activity
The following genes and proteins are directly implicated in toxin transmembrane transporter activity or related transport processes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRPV1 | Ion channel involved in pain and toxin detection | Target for pain relief and toxin-induced nociception |
| TMEM233 | Modulates NaV1.7 function in response to nettle toxins | Pain signaling and toxin transport |
| LptC | Component of LptB2FGC complex for LPS transport | Bacterial outer membrane biogenesis and virulence [5,7] |
| LptB2FGC | ABC transporter complex that extracts LPS | Essential for LPS transport and bacterial survival [5,7] |
| SLC41A1 | Magnesium ion transporter | LPS-induced pyroptosis in dental stem cells |
| Clathrin | Mediates conventional endocytosis | Toxin entry via endocytic pathways |
| Caveolin | Component of caveolae-mediated endocytosis | Unconventional toxin uptake |
| NaV1.7 | Voltage-gated sodium channel | Pain signaling modulated by toxins |
| LPS | Bacterial endotoxin | Substrate for LptB2FGC transport [5,7] |
| OmpF | Outer membrane porin | Outer membrane permeability to toxins |
| OmpC | Outer membrane porin | Outer membrane permeability |
| TolC | Outer membrane efflux channel | Toxin efflux and transport |
| AcrAB | Multidrug efflux pump | Toxin transport and resistance |
| MDR1 | Multidrug resistance transporter | Natural product-drug interactions |
| BCRP | Breast cancer resistance protein | Transporter-mediated drug interactions |
| OATP | Organic anion transporting polypeptide | Natural product-drug interactions |
| P-gp | P-glycoprotein efflux pump | Toxin transport and drug resistance |
How Is toxin transmembrane transporter activity Regulated?
The activity of toxin transmembrane transporters is regulated at multiple levels. In bacteria, the LptB2FGC complex is regulated by the conformational plasticity of LptC, which controls LPS transport efficiency. Additionally, outer membrane permeability, which affects toxin access to transporters, is modulated by porins and efflux pumps. In eukaryotic cells, unconventional endocytic mechanisms that mediate toxin uptake can be regulated by signaling pathways and membrane lipid composition. Natural product-drug interactions can also influence transporter activity, as many natural products modulate the function of transporters like P-gp, BCRP, and OATP. Furthermore, inflammatory stimuli such as LPS can upregulate or activate transporters, leading to downstream effects like pyroptosis. These regulatory mechanisms ensure that toxin transport is tightly controlled and responsive to cellular needs.
toxin transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TMEM233 | Pain signaling modulated by nettle toxins | Knockout in sensory neurons |
| SLC41A1 | LPS-induced pyroptosis in dental stem cells | Point mutation to alter magnesium transport |
| LptC | Bacterial outer membrane biogenesis and virulence | Knockout in E. coli [5,7] |
| TRPV1 | Pain and neurogenic inflammation | Overexpression in HEK293 cells |
| NaV1.7 | Pain perception | Knock-in of human mutations in mice |
Pain and neurogenic inflammation
Toxins that target ion channels such as NaV1.7 can modulate pain signaling. Stinging nettle toxins target TMEM233 to modulate NaV1.7 function, leading to altered pain perception. TRPV1, a capsaicin receptor, is also involved in pain and toxin detection, and its activity can be influenced by toxins. These mechanisms are relevant to neurogenic inflammation and chronic pain conditions.
Bacterial infections and sepsis
The transport of LPS across bacterial membranes is essential for outer membrane integrity and virulence. The LptB2FGC complex mediates LPS transport, and its dysfunction leads to bacterial death [5,7]. Outer membrane permeability, controlled by porins and efflux pumps, affects susceptibility to antibiotics and toxins. In humans, LPS can trigger inflammatory responses, including pyroptosis of dental stem cells via SLC41A1-mediated magnesium efflux. These pathways are critical in sepsis and periodontal disease.
Inflammatory cell death and tissue damage
LPS-induced mitochondrial damage via SLC41A1-mediated magnesium ion efflux leads to pyroptosis of dental stem cells. This highlights how toxin transport and ion homeostasis are linked to inflammatory cell death. Understanding these mechanisms could lead to therapies for inflammatory diseases and tissue regeneration.
From toxin transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TMEM233 mediate toxin-induced pain? | TMEM233 knockout mouse or sensory neuron cell line |
| How does SLC41A1 regulate LPS-induced pyroptosis? | SLC41A1 point-mutation knock-in in dental stem cells |
| What is the role of LptC in LPS transport? | LptC knockout or tagged knock-in in E. coli [5,7] |
| Can TRPV1 be targeted to block toxin entry? | TRPV1 overexpression and knockout in HEK293 cells |
| How do unconventional endocytic pathways affect toxin uptake? | Knockout of caveolin or clathrin in mammalian cells |
| What is the impact of efflux pumps on toxin resistance? | Overexpression of AcrAB-TolC in bacteria |
How to Study the toxin transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for toxin transport | Identify novel transporters |
| Affinity purification-mass spectrometry | Protein-protein interactions | Map LptB2FGC complex [5,7] |
| Live-cell imaging | Toxin internalization and trafficking | Study endocytic pathways |
| Patch-clamp electrophysiology | Ion channel activity | Measure NaV1.7 modulation by toxins |
| Ion flux assay | Magnesium efflux | Assess SLC41A1 function |
| Transport assays | Substrate transport rates | Evaluate transporter activity |
| RNA-seq | Gene expression changes | Identify regulated transporters |
| Proteomics | Protein abundance and modifications | Study LptC conformational changes |
Genetic screens and CRISPR libraries
CRISPR library screening is a powerful method to identify genes involved in toxin transport. By using genome-wide knockout libraries, researchers can uncover novel transporters and regulatory factors. This approach has been used to study endocytic mechanisms and toxin entry.
Proteomics and interactomics
Proteomic approaches can identify proteins that interact with toxins or transporters. For example, affinity purification coupled with mass spectrometry can reveal components of the LptB2FGC complex [5,7]. These methods help map the molecular machinery of toxin transport.
Imaging and transport assays
Fluorescently labeled toxins can be used to visualize transport in live cells. Imaging techniques such as confocal microscopy can track toxin internalization and intracellular trafficking. Transport assays with radioactive or fluorescent substrates can quantify transporter activity.
Electrophysiology and ion flux measurements
For toxins that modulate ion channels, patch-clamp electrophysiology can measure changes in ion currents. This is particularly relevant for TMEM233 and NaV1.7. Ion flux assays can also detect magnesium efflux via SLC41A1.
How CRISPR Can Be Used to Study GO:0019534 toxin transmembrane transporter activity
Knockout
CRISPR knockout is used to completely abolish the function of a gene involved in toxin transport. For example, knocking out TMEM233 can reveal its role in toxin-induced pain. Similarly, LptC knockout in bacteria can disrupt LPS transport and outer membrane integrity [5,7]. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutations can be introduced to study specific amino acid residues critical for transporter activity. For instance, mutating SLC41A1 can alter magnesium efflux and affect LPS-induced pyroptosis. Point mutations in LptC can reveal conformational changes required for LPS transport. These models provide fine-grained mechanistic insights.
Knock-in
Knock-in models allow the introduction of tagged or mutant versions of a gene. Tagged knock-in of LptC can facilitate imaging and purification of the LptB2FGC complex [5,7]. Knock-in of human NaV1.7 mutations can model pain disorders. These models are valuable for tracking protein localization and function.
Overexpression
Overexpression of transporters can be used to study gain-of-function effects and substrate specificity. Overexpressing TRPV1 in HEK293 cells can enhance toxin sensitivity. Overexpression of efflux pumps like AcrAB-TolC can increase toxin resistance. This approach is useful for biochemical and structural studies.
How EDITGENE Supports toxin transmembrane transporter activity Research
Researchers studying toxin transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in toxin transport, pain signaling, or inflammatory responses. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for toxin transmembrane transporter activity research.
Frequently Asked Questions About toxin transmembrane transporter activity
What is toxin transmembrane transporter activity?
It is a molecular function (GO:0019534) that enables the transfer of a toxin from one side of a membrane to the other, as defined by the Gene Ontology [1,4].
What genes are involved in toxin transmembrane transporter activity?
Key genes include TRPV1, TMEM233, LptC, LptB2FGC, SLC41A1, and various endocytic and efflux pump components [1,2,4,5,6,7,8].
How do toxins cross cell membranes?
Toxins can cross membranes via dedicated transporters, such as the LptB2FGC complex for LPS, or through unconventional endocytic mechanisms [2,5,7].
What diseases are associated with toxin transmembrane transporter activity?
It is linked to pain signaling, bacterial infections, sepsis, and inflammatory cell death such as pyroptosis [4,5,6].
What is the role of TMEM233 in toxin transport?
TMEM233 is targeted by stinging nettle toxins to modulate NaV1.7 function, affecting pain signaling.
How does SLC41A1 contribute to LPS-induced pyroptosis?
SLC41A1 mediates magnesium ion efflux, which leads to mitochondrial damage and pyroptosis in dental stem cells upon LPS exposure.
What is the LptB2FGC complex?
It is an ABC transporter complex that extracts LPS from the inner membrane and transports it to the outer membrane in bacteria [5,7].
Can CRISPR be used to study toxin transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the function of toxin transporters [4,5,6].
What research methods are used to study toxin transmembrane transporter activity?
Methods include CRISPR screens, proteomics, live-cell imaging, patch-clamp electrophysiology, and transport assays [2,3,4,5].
How can I create a knockout model for a toxin transporter gene?
EDITGENE provides custom CRISPR knockout cell models for genes like TMEM233, SLC41A1, and LptC to support your research [4,5,6].
Conclusion
Toxin transmembrane transporter activity (GO:0019534) is a fundamental molecular function that governs the movement of poisonous substances across membranes. It plays critical roles in bacterial virulence, pain signaling, and inflammatory diseases [1,4,5,6]. Understanding the genes and mechanisms involved, such as TMEM233, LptB2FGC, and SLC41A1, offers opportunities for therapeutic intervention [4,5,6]. CRISPR-based models are indispensable for dissecting these pathways and identifying new targets. EDITGENE's comprehensive services can accelerate research in this field, from knockout to knock-in and screening.
References
- 1. Bevan S et al.. 2014. TRPV1.. Handb Exp Pharmacol 222:207-45 PMID: 24756708
- 2. Renard HF et al.. 2021. Unconventional endocytic mechanisms.. Curr Opin Cell Biol 71:120-129 PMID: 33862329
- 3. Bi Y et al.. 2023. Transporter-mediated Natural Product-Drug Interactions.. Planta Med 89(2):119-133 PMID: 35304735
- 4. Jami S et al.. 2023. Pain-causing stinging nettle toxins target TMEM233 to modulate Na(V)1.7 function.. Nat Commun 14(1):2442 PMID: 37117223
- 5. Klausnitzer A et al.. 2025. Conformational Plasticity of LptC Regulates Lipopolysaccharide Transport by the LptB(2)FGC Complex.. J Am Chem Soc 147(39):35718-35729 PMID: 40974309
- 6. Liu Y et al.. 2025. LPS-Induced Mitochondrial Damage via SLC41A1-Mediated Magnesium Ion Efflux Leads to the Pyroptosis of Dental Stem Cells.. Adv Sci (Weinh) 12(42):e05666 PMID: 40831212
- 7. Wilson A et al.. 2022. The transmembrane α-helix of LptC participates in LPS extraction by the LptB(2) FGC transporter.. Mol Microbiol 118(1-2):61-76 PMID: 35678757
- 8. Nakae T. 1986. Outer-membrane permeability of bacteria.. Crit Rev Microbiol 13(1):1-62 PMID: 3013502
